STOK STOKE THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Public Offering Stoke Therapeutics, Inc. entered into an underwriting agreement for a public offering of its common stock and pre-funded warrants, with expected net proceeds of approximately $119.8 million to fund research and development.Get access to all SEC 8-K filings of the STOKE THERAPEUTICS INC